- Center on Health Equity & Access
- Clinical
- Health Care Cost
- Health Care Delivery
- Insurance
- Policy
- Technology
- Value-Based Care
Dr Joseph Kvedar Discusses Wearables and the Patient-Insurer Relationship
How new technologies like mHealth and wearables may affect insurance providers and patient costs, according to Joseph C. Kvedar, MD, vice president of Connected Health at Partners HealthCare.
How new technologies like mHealth and wearables may affect insurance providers and patient costs, according to Joseph C. Kvedar, MD, vice president of Connected Health at Partners HealthCare.
Transcript (modified)
How will mHealth and wearables change the patient-insurer relationship?
Well the most interesting example of that is a firm called Oscar, which you might be aware of. It’s a new, innovative insurer and they’ve set up a program where if people wear an “activity tracker,” they can get credit on their premium cost for being more active. I expected to see that happen. Progressive Insurance, which is an auto insurance company, has a program where if you put a sensor on your car and you drive safely, they’ll give you premium credits. So I expect more and more of that to happen in the insurance industry.
Maybe what you’ll see in the next few years is a bit of a divergence because the focus will be on healthcare providers who monitor things like blood pressure and diabetes, and these insurers may take up the improvement in health with their employer colleagues. That would make some sense because there are wearables that fit both categories now.
The Latest in New and Emerging Therapies in Schizophrenia: Dr Megan Ehret
October 22nd 2024In addition to Cobenfy being approved for schizophrenia, there are other drugs with novel mechanisms being studied that may mean combination therapies or, at least, more options for patients in the future.
Read More
Sustaining Compassionate Trauma Care Across Communities
September 30th 2024September is National Recovery Month, and we are bringing you another limited-edition month-long podcast series with our Strategic Alliance Partner, UPMC Health Plan. In our final episode, we speak with Lyndra Bills, MD, and Shari Hutchison, MS.
Listen
A Novel Approach to Chronic GVHD With Axatilimab: Dr Daniel Wolff
October 18th 2024The latest therapy approved to treat chronic graft-versus-host disease (GVHD) has a new target different than the other approved therapies. Daniel Wolff, MD, also discusses future research on axatilimab to treat chronic GVHD earlier.
Read More
Bimekizumab Poised to Tackle Unmet HS Treatment Needs
October 18th 2024Hidradenitis suppurativa (HS) is an inflammatory, chronic disease with very high symptom and physical burdens, and it can get progressively worse over time if it's inadequately treated, explained Amit Garg, MD, founding chair, Department of Dermatology, Northwell Health.
Read More
